University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

Clinical Care Options in collaboration with the National Eczema Association is hosting an innovative and engaging symposium IL-13 Inhibition in Moderate to Severe Atopic Dermatitis: A Clinical Skills ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

Available now on the AISight® Image Management System (IMS), this research tool enables identification of skin lesions based on possible entities in the specimen with the potential to help expedite ...

PathAI has launched the PathAssist Derm AI tool, which is designed for orienting, detecting, and measuring skin lesions. This new offering, now available on the AISight image management system ...

NICE judged that ‘more data is needed to be certain that these technologies do not incorrectly detect or miss skin cancer in people with black or brown skin’. Skin Analytics s ...

The Skin Analytics AI tool has already seen more patients than a dermatologist would in their entire career. Maddy Mussen ...

Dermatology Nursing ... Specific terminology is used to describe the characteristics of skin lesions (color, configuration, distribution, type of lesion, and the lesion pattern) which can then ...